WNT Signalling Is Both an Inducer and Effector of Glucagon-Like Peptide-1

Diabetologia - Germany
doi 10.1007/s00125-008-1109-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Glucagon-Like Peptide-1 and Satiety

Nature
Multidisciplinary
1997English

Effects of Gastric Inhibitory Polypeptide, Glucagon-Like Peptide-1 and Glucagon-Like Peptide-1 Receptor Agonists on Bone Cell Metabolism

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Cardiovascular and Hemodynamic Effects of Glucagon-Like Peptide-1

Reviews in Endocrine and Metabolic Disorders
EndocrinologyMetabolismDiabetes
2014English

Equine Glucagon-Like Peptide-1 Receptor Physiology

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2018English

Glucagon-Like Peptide-1 Is Involved in Sodium and Water Homeostasis in Humans

Digestion
Gastroenterology
2006English

Modulation of Kv1.3 by the Gut Peptide Glucagon-Like Peptide 1

Biophysical Journal
Biophysics
2019English

Differences in Signalling, Trafficking and Glucoregulatory Properties of Glucagon-Like Peptide-1 Receptor Agonists Exendin-4 and Lixisenatide

2019English

Glucagon-Like Peptide-1 Receptor (GLP1R; GLP-1R)

Science-Business eXchange
2009English

Cardiovascular Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy